Dr. Friba Nurmukhamma | Medicine | Best Researcher Award

Dr. Friba Nurmukhamma | Medicine | Best Researcher Award

Khoja Akhmet Yassawi International Kazakh-Turkish University | Kazakhstan

Dr. Friba NurmukhammadNasrullakyzy is a cardiologist, senior researcher, and PhD scholar specializing in cardiovascular pathology, with a particular focus on coronary artery disease (CAD), stenting, and post-coronary artery bypass grafting (CABG) outcomes. Her research explores the mechanisms of high residual platelet reactivity (HRPR) and dyslipidemia, contributing to improved treatment algorithms and predictive models aimed at reducing mortality in patients with complex cardiovascular conditions. Dr. Friba’s innovative work integrates clinical insights with advanced diagnostic methodologies and personalized therapeutic approaches, emphasizing non-statin therapies, platelet reactivity modulation, and functional diagnostics in cardiology. She has authored multiple peer-reviewed publications indexed in Scopus and other scientific databases, reflecting a growing international research presence. Her Scopus h-index is 3, and her research impact is further supported by citations across both Scopus and Google Scholar databases. Dr. Friba’s current projects involve developing mortality prediction scales and individualized treatment algorithms for patients with HRPR, aiming to advance precision medicine in cardiology. Her scientific contributions underscore her commitment to translational cardiovascular research and her role in fostering evidence-based practices within clinical cardiology.

Profile

Scopus | ORCID

Featured Publications

Mussagaliyeva, A., Zhangelova, S., Danyarova, L., Nurmukhammad, F., Kapsultanova, D., Sakhov, O., Rustamova, F., Sugraliyev, A., & Akhmentayeva, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients undergoing repeat revascularization: Insights from Kazakhstan. Diseases, 13(11), 365.

Nurmukhammad, F. N., Zhangelova, S. B., & Kapsultanova, D. A. (2025). Non-statin therapy in patients with elevated LDL-C and high platelet reactivity: A narrative review. Medical Journal of Malaysia, 80(2), 258–265.

Zhangelova, S. B., Nurmukhammad, F. N., & Nurdinov, N. (2023). High residual platelet reactivity as a predictor of atherothrombosis in patients with coronary heart disease. Science and Healthcare, 25(3), 25–31.

Mussagaliyeva, A., Zhangelova, S., Nurmukhammad, F., & Kapsultanova, D. (2025). Residual platelet reactivity and dyslipidemia in post-CABG patients: Preprint insights from Kazakhstan. Preprints, 2025(09), 2498.

Dr. Eleni Memi | Medicine | Best Researcher Award

Dr. Eleni Memi | Medicine | Best Researcher Award

Dr. Eleni Memi | Clinician | National and Kapodistrian University of Athens | Greece

Dr. Eleni Memi is a distinguished medical scientist and endocrinologist from Greece whose research focuses on endocrinology, diabetes, metabolism, reproductive endocrinology, and thyroid gland pathophysiology. Her scientific contributions span both clinical and translational aspects of endocrine disorders, with special emphasis on hormonal regulation, metabolic diseases, glycosaminoglycans, and reproductive endocrinology in women. Dr. Memi has made substantial advancements in understanding the interplay between thyroid dysfunction, glucocorticoid activity, and reproductive health, integrating molecular mechanisms with clinical applications. Her work in endocrine-related metabolic disorders has contributed to novel insights into hormonal pathways and disease outcomes. She has authored several influential papers and a book chapter published by Elsevier. Her scholarly impact is reflected in Scopus with 72 citations, 12 documents, and an h-index of 5, while Google Scholar reports 129 citations, an h-index of 6, and an i10-index of 6, underscoring her growing academic influence in medical research.

Publication Profile

Scopus | ORCID | Google Scholar

Featured Publications

  1. Memi, E., Pavli, P., Maria, P., Vrachnis, N., & Mastorakos, G. (2024). Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. Reviews in Endocrine and Metabolic Disorders.

  2. Alexandraki, K. I., Violetis, O., Memi, E., Fryssira, H., Papanikolaou, V., Papagianni, M., & Mastorakos, G. (2025). A rare combination of hypogonadotropic hypogonadism, GH deficiency and rectal atresia in a female with an FGFR1 variant: A case report and systematic review of the literature. Endocrine.

  3. Kanouta, F., Karampitsakos, T., Memi, E., Vrachnis, N., Macut, D., & Mastorakos, G. (2025). Epigenetic effects of endogenous and exogenous glucocorticosteroids during pregnancy on the offspring: A systematic-narrative review. Hormones (Athens).

  4. Pontikides, N., Karras, S., Kaprara, A., Anagnostis, P., Mintziori, G., Goulis, D. G., Memi, E., & Krassas, G. (2014). Genetic basis of familial isolated hyperparathyroidism: A case series and a narrative review of the literature. Journal of Bone and Mineral Metabolism.

  5. Memi, E., Karakiulakis, G., Goma, F., & Papakonstantinou, E. (2012). The functional role of glycosaminoglycans in the pathophysiology of the thyroid gland and their putative role as prognostic, diagnostic and therapeutic agents in thyroid pathologies. Review of Clinical Pharmacology and Pharmacokinetics.